zintick

Enanta Pharmaceuticals ENTA

Enanta Pharmaceuticals Inc · Nasdaq · Pharmaceutical Preparations

$11.55-5.17%close on Oct. 28, 2026 · volume 281K · Yahoo Finance

Price, last 47 sessions

$12.00$13.00$14.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $14.15 · low $11.10 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 7 →
  • 8-KOct. 28, 2026, 7:14 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedEnanta Pharmaceuticals Announces Planned Retirement of CEO Jay R. Luly by February 1, 2027 and Names Tara L. Kieffer Chief Operating Officer

  • SCHEDULE 13GOct. 27, 2026, 4:09 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 8:26 a.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 8:19 a.m. ETView on SEC.gov
  • 10-QAug. 12, 2026, 7 a.m. ETView on SEC.gov
  • 4Aug. 10, 2026, 9 a.m. ETView on SEC.gov
  • 8-KAug. 10, 2026, 4:05 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits